PGP and diffuse large B-cell lymphoma: Our observations showing that SipA downregulates the expression of P-gp in diffuse large B-cell lymphoma are especially significant, given that overexpression of this efflux transporter severely limits the use of numerous first-line anticancer drugs, such as doxorubicin currently used in the treatment of DLBCL.